Journal
MICROMACHINES
Volume 12, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/mi12080967
Keywords
human induced pluripotent stem cells; podocytes; endothelial cells; kidney glomerulus; disease models; organ-on-a-chip; glomerulus chip; stem cell technologies; microfluidics; personalized medicine
Categories
Funding
- Department of Medicine at Duke University
- MEDx Pilot Grant on Biomechanics in Injury or injury repair
- BurroughsWellcome Fund PDEP Career Transition Ad Hoc Award
- Duke Incubation Fund from the Duke Innovation & Entrepreneurship Initiative
Ask authors/readers for more resources
This study engineered a personalized glomerulus chip system using human induced pluripotent stem cells, successfully mimicking the structure and some functions of the glomerular filtration barrier, and modeling glomerular injury and proteinuria. The research has the potential to advance studies of kidney disease mechanisms and the discovery of personalized therapies, and could serve as a blueprint for the development of more personalized organ chip and 'body-on-a-chip' models in the future.
Progress in understanding kidney disease mechanisms and the development of targeted therapeutics have been limited by the lack of functional in vitro models that can closely recapitulate human physiological responses. Organ Chip (or organ-on-a-chip) microfluidic devices provide unique opportunities to overcome some of these challenges given their ability to model the structure and function of tissues and organs in vitro. Previously established organ chip models typically consist of heterogenous cell populations sourced from multiple donors, limiting their applications in patient-specific disease modeling and personalized medicine. In this study, we engineered a personalized glomerulus chip system reconstituted from human induced pluripotent stem (iPS) cell-derived vascular endothelial cells (ECs) and podocytes from a single patient. Our stem cell-derived kidney glomerulus chip successfully mimics the structure and some essential functions of the glomerular filtration barrier. We further modeled glomerular injury in our tissue chips by administering a clinically relevant dose of the chemotherapy drug Adriamycin. The drug disrupts the structural integrity of the endothelium and the podocyte tissue layers, leading to significant albuminuria as observed in patients with glomerulopathies. We anticipate that the personalized glomerulus chip model established in this report could help advance future studies of kidney disease mechanisms and the discovery of personalized therapies. Given the remarkable ability of human iPS cells to differentiate into almost any cell type, this work also provides a blueprint for the establishment of more personalized organ chip and 'body-on-a-chip' models in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available